These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 20383934

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Isolation and characterization of some potential impurities in ropinirole hydrochloride.
    Sahasrabuddhey B, Nautiyal R, Acharya H, Khyade S, Luthra PK, Deshpande PB.
    J Pharm Biomed Anal; 2007 Mar 12; 43(4):1587-93. PubMed ID: 17207602
    [Abstract] [Full Text] [Related]

  • 4. Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate.
    Bharathi Ch, Prabahar KJ, Prasad ChS, Srinivasa Rao M, Trinadhachary GN, Handa VK, Dandala R, Naidu A.
    Pharmazie; 2008 Jan 12; 63(1):14-9. PubMed ID: 18271296
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodium.
    Saravanan M, Siva Kumari K, Pratap Reddy P, Naidu MN, Moses Babu J, Srivastava AK, Lakshmi Kumar T, Chandra Sekhar BV, Satyanarayana B.
    J Pharm Biomed Anal; 2008 Nov 04; 48(3):708-15. PubMed ID: 18755563
    [Abstract] [Full Text] [Related]

  • 9. Identification and characterization of new impurity in didanosine.
    Srinivasa Rao DV, Srinivas N, Bharathi Ch, Prasad ChS, Dandala R, Naidu A.
    J Pharm Biomed Anal; 2007 Nov 05; 45(3):516-20. PubMed ID: 17624711
    [Abstract] [Full Text] [Related]

  • 10. Identification and characterization of potential impurities of amlodipine maleate.
    Sudhakar P, Nirmala M, Moses Babu J, Vyas K, Madhusudan Reddy G, Vijaya Bhaskar B, Pratap Reddy P, Mukkanti K.
    J Pharm Biomed Anal; 2006 Feb 24; 40(3):605-13. PubMed ID: 16324814
    [Abstract] [Full Text] [Related]

  • 11. Isolation and characterization of a potential process related impurity of phenazopyridine HCl by preparative HPLC followed by MS-MS and 2D-NMR spectroscopy.
    Rao RN, Maurya PK, Raju AN.
    J Pharm Biomed Anal; 2009 Jul 12; 49(5):1287-91. PubMed ID: 19376664
    [Abstract] [Full Text] [Related]

  • 12. Identification and structural elucidation of an unknown impurity in carbamazepine active pharmaceutical ingredient by liquid chromatography-tandem mass spectrometry and semi-preparative chromatographic isolation.
    Thomas S, Mathela CS, Agarwal A, Paul SK.
    J Pharm Biomed Anal; 2011 Sep 10; 56(2):423-8. PubMed ID: 21676571
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Identification, characterization and quantification of new impurities by LC-ESI/MS/MS and LC-UV methods in rivastigmine tartrate active pharmaceutical ingredient.
    Thomas S, Shandilya S, Bharati A, Paul SK, Agarwal A, Mathela CS.
    J Pharm Biomed Anal; 2012 Jan 05; 57():39-51. PubMed ID: 21880452
    [Abstract] [Full Text] [Related]

  • 15. Identification and characterization of potential impurities of donepezil.
    Krishna Reddy KV, Moses Babu J, Kumar PA, Chandrashekar ER, Mathad VT, Eswaraiah S, Reddy MS, Vyas K.
    J Pharm Biomed Anal; 2004 Sep 03; 35(5):1047-58. PubMed ID: 15336352
    [Abstract] [Full Text] [Related]

  • 16. Identification and characterization of potential impurities of valsartan, AT1 receptor antagonist.
    Sampath A, Reddy AR, Yakambaram B, Thirupathi A, Prabhakar M, Reddy PP, Reddy VP.
    J Pharm Biomed Anal; 2009 Oct 15; 50(3):405-12. PubMed ID: 19560892
    [Abstract] [Full Text] [Related]

  • 17. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
    Srinivasu P, Subbarao DV, Vegesna RV, Sudhakar Babu K.
    J Pharm Biomed Anal; 2010 May 01; 52(1):142-8. PubMed ID: 20053517
    [Abstract] [Full Text] [Related]

  • 18. Structural identification and characterization of impurities in ceftizoxime sodium.
    Bharathi Ch, Prasad ChS, Bharathi DV, Shankar R, Rao VJ, Dandala R, Naidu A.
    J Pharm Biomed Anal; 2007 Jan 17; 43(2):733-40. PubMed ID: 16950586
    [Abstract] [Full Text] [Related]

  • 19. Isolation and identification of a new impurity in mitoxantrone hydrochloride.
    Haiyan L.
    Pharmazie; 2009 Jun 17; 64(6):376-9. PubMed ID: 19618673
    [Abstract] [Full Text] [Related]

  • 20. Identification and characterization of process related impurities in chloroquine and hydroxychloroquine by LC/IT/MS, LC/TOF/MS and NMR.
    Dongre VG, Ghugare PD, Karmuse P, Singh D, Jadhav A, Kumar A.
    J Pharm Biomed Anal; 2009 May 01; 49(4):873-9. PubMed ID: 19201565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.